Lotze MT - Search Results

1

Interleukin-3 induces proliferation but not lymphokine activated killer activity from human and murine mononuclear cells.

Jablons DM, Donohue R, Kawakami Y, Young JD, Lotze MT. Jablons DM, et al. Among authors: lotze mt. Eur Cytokine Netw. 1990 May-Jun;1(2):91-8. Eur Cytokine Netw. 1990. PMID: 2102814

2

IL-4 regulates IL-2 induction of lymphokine-activated killer activity from human lymphocytes.

Kawakami Y, Custer MC, Rosenberg SA, Lotze MT. Kawakami Y, et al. Among authors: lotze mt. J Immunol. 1989 May 15;142(10):3452-61. J Immunol. 1989. PMID: 2654291

3

Derivation of cells with lytic activity against fresh and cultured tumors from human bone marrow.

Jablons DM, Lotze MT. Jablons DM, et al. Among authors: lotze mt. J Surg Res. 1988 Apr;44(4):404-16. doi: 10.1016/0022-4804(88)90183-7. J Surg Res. 1988. PMID: 3258943

4

IL-2-based immunotherapy alters circulating neutrophil Fc receptor expression and chemotaxis.

Jablons D, Bolton E, Mertins S, Rubin M, Pizzo P, Rosenberg SA, Lotze MT. Jablons D, et al. Among authors: lotze mt. J Immunol. 1990 May 1;144(9):3630-6. J Immunol. 1990. PMID: 2158514

5

Mechanisms of immunologic antitumor therapy: lessons from the laboratory and clinical applications.

Lotze MT, Custer MC, Bolton ES, Wiebke EA, Kawakami Y, Rosenberg SA. Lotze MT, et al. Hum Immunol. 1990 Jun;28(2):198-207. doi: 10.1016/0198-8859(90)90020-p. Hum Immunol. 1990. PMID: 2190952 Review.

6

Induction of interferon-beta 2/interleukin-6 (IL-6) by cytokine administration and detection of circulating interleukin-6 in the tumor-bearing state.

Jablons DM, McIntosh JK, Mulé JJ, Nordan RP, Rudikoff S, Lotze MT. Jablons DM, et al. Among authors: lotze mt. Ann N Y Acad Sci. 1989;557:157-60; discussion 160-1. doi: 10.1111/j.1749-6632.1989.tb24008.x. Ann N Y Acad Sci. 1989. PMID: 2472087 No abstract available.

7

In vivo induction of IL-6 by administration of exogenous cytokines and detection of de novo serum levels of IL-6 in tumor-bearing mice.

McIntosh JK, Jablons DM, Mulé JJ, Nordan RP, Rudikoff S, Lotze MT, Rosenberg SA. McIntosh JK, et al. Among authors: lotze mt. J Immunol. 1989 Jul 1;143(1):162-7. J Immunol. 1989. PMID: 2499626

8

IL-6/IFN-beta-2 as a circulating hormone. Induction by cytokine administration in humans.

Jablons DM, Mulé JJ, McIntosh JK, Sehgal PB, May LT, Huang CM, Rosenberg SA, Lotze MT. Jablons DM, et al. Among authors: lotze mt. J Immunol. 1989 Mar 1;142(5):1542-7. J Immunol. 1989. PMID: 2783945

9

Interleukin 4 promotes the growth of tumor-infiltrating lymphocytes cytotoxic for human autologous melanoma.

Kawakami Y, Rosenberg SA, Lotze MT. Kawakami Y, et al. Among authors: lotze mt. J Exp Med. 1988 Dec 1;168(6):2183-91. doi: 10.1084/jem.168.6.2183. J Exp Med. 1988. PMID: 3264324 Free PMC article.

10

Expansion of tumor-infiltrating lymphocytes from human tumors using the T-cell growth factors interleukin-2 and interleukin-4.

Kawakami Y, Haas GP, Lotze MT. Kawakami Y, et al. Among authors: lotze mt. J Immunother Emphasis Tumor Immunol. 1993 Nov;14(4):336-47. doi: 10.1097/00002371-199311000-00014. J Immunother Emphasis Tumor Immunol. 1993. PMID: 8280717

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

572 results

Search Page

Filters